06:47 AM EDT, 07/31/2025 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) reported Q2 earnings Thursday of $0.16 per diluted share, up from $0.01 a year earlier.
One analyst polled by FactSet expected $0.13.
Revenue for the quarter ended June 30 was $70 million, compared with $57.2 million a year earlier.
Analysts polled by FactSet expected $63.8 million.